1. Home
  2. STOK vs VEL Comparison

STOK vs VEL Comparison

Compare STOK & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • VEL
  • Stock Information
  • Founded
  • STOK 2014
  • VEL 2004
  • Country
  • STOK United States
  • VEL United States
  • Employees
  • STOK N/A
  • VEL N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • VEL Finance: Consumer Services
  • Sector
  • STOK Health Care
  • VEL Finance
  • Exchange
  • STOK Nasdaq
  • VEL Nasdaq
  • Market Cap
  • STOK 796.0M
  • VEL 617.5M
  • IPO Year
  • STOK 2019
  • VEL 2020
  • Fundamental
  • Price
  • STOK $13.27
  • VEL $19.72
  • Analyst Decision
  • STOK Strong Buy
  • VEL Buy
  • Analyst Count
  • STOK 7
  • VEL 5
  • Target Price
  • STOK $21.40
  • VEL $20.20
  • AVG Volume (30 Days)
  • STOK 677.9K
  • VEL 35.9K
  • Earning Date
  • STOK 11-05-2024
  • VEL 10-31-2024
  • Dividend Yield
  • STOK N/A
  • VEL N/A
  • EPS Growth
  • STOK N/A
  • VEL 44.34
  • EPS
  • STOK N/A
  • VEL 1.75
  • Revenue
  • STOK $15,157,000.00
  • VEL $151,518,000.00
  • Revenue This Year
  • STOK $78.03
  • VEL N/A
  • Revenue Next Year
  • STOK $12.23
  • VEL $10.91
  • P/E Ratio
  • STOK N/A
  • VEL $11.27
  • Revenue Growth
  • STOK 71.38
  • VEL 38.59
  • 52 Week Low
  • STOK $3.35
  • VEL $10.81
  • 52 Week High
  • STOK $17.58
  • VEL $20.37
  • Technical
  • Relative Strength Index (RSI)
  • STOK 53.46
  • VEL 59.46
  • Support Level
  • STOK $11.23
  • VEL $19.48
  • Resistance Level
  • STOK $13.14
  • VEL $19.69
  • Average True Range (ATR)
  • STOK 0.75
  • VEL 0.27
  • MACD
  • STOK 0.20
  • VEL -0.01
  • Stochastic Oscillator
  • STOK 86.89
  • VEL 89.69

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

About VEL Velocity Financial Inc.

Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.

Share on Social Networks: